Bristol Myers Squibb Associate Director - Translational Research in Cambridge, Massachusetts
Associate Director - Translational Research
Bristol-Myers Squibb R&D is a science-driven, passionate organization determined to discover, develop and deliver medicines that have the potential to transform the lives of patients and establish new standards of care in areas of high unmet need. Patients’ needs and scientific discovery are our driving force. The new Bristol-Myers Squibb research site in Cambridge’s Kendall Square will position our scientific team in the heart of a vibrant ecosystem of world-class science, innovation and business opportunities. Our scientists will focus on novel targets and pathways for tumors that are refractory to current Immuno-Oncology therapies. These are significant challenges that will require innovative solutions from the biopharma, biotech and academic communities.
Role / Responsibilities
We are seeking an experienced scientist to join our Translational Research group in our new state-of-the-art facility. The qualified candidate is a highly motivated, interactive, and creative individual that possesses the ability to work across a highly matrixed environment to advance the translational research efforts. The candidate will be expected to lead a team of scientists and effectively collaborate with colleagues in the oncology, immunology and immuno-oncology groups, as well as liaise with the wider translational medicine, discovery and clinical teams. To be at the forefront of elucidating and overcoming resistance to IO therapies, should encourage scientists who are passionate problem solvers and thrive on a challenge that is clinically-vital to consider this opportunity.
MD, PhD or MD/PhD in Cancer Biology, or equivalent advanced biology degree
Experienced scientist with 5-10+ years’ of post-graduate research experience, with a minimum of 3 years in a drug discovery or translational setting
Minimum 3+ years’ recent experience in leading scientific teams in an academic or industry setting
Ideally candidate will have in-depth knowledge / understanding of various mechanisms of therapeutic response and resistance utilizing in vitro , in vivo (and potentially ex vivo ) patient-derived models
Participated in clinical studies to better characterize the molecular underpinnings of therapeutic resistance in patient cohorts and correlation with clinical outcome
A track record of independent critical thinking and scientific achievement demonstrated by first authorship in recent high impact publications
Exposure to cancer immunotherapy including immune-checkpoint blockade with knowledge of current therapeutic landscape is highly desirable
Knowledge of immune-phenotyping by flow cytometry would be beneficial
Experience in balanced experimental design, data visualization and basic statistical analysis are desirable
Prior role in multidisciplinary projects and teams with ability to integrate cross-functional information, desired but not required
Experience with managing CRO relationships and collaborating with KOL’s would be advantageous
Excellent interpersonal skills and ability to communicate, both written and oral effectively and efficiently within the BMS organization and with external partners/collaborators
Thrives in fast-paced, dynamic work environment, bringing a pro-active mentality to the role
We follow the science and we’ll continue to invest in translational medicine research, deepen our understanding of disease biology and uncover insights about predictive biomarkers with the ultimate goal of making precision medicine a reality for more patients.
Bristol-Myers Squibb is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or protected veteran status.